References
- Korb DR, Greiner JV, Finnemore VM, Allansmith MR. Biomicroscopy of papillae associated with wearing of soft contact lenses. Brit J Ophthalmol. 1983;67:733–736.
- Allansmith MR, Korb DR, Greiner JV, et al. Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol. 1977;83: 697–708.
- Robin JB, Regis-Pacheco LF, May WN, et al. Giant papillary conjunctivitis associated with an extruded scleral buckle. (Case report). Arch Ophthalmol. 1987;105: 619.
- Carlson AN, Wilhelmus KR. Giant papillary conjunctivitis associated with cyanoacrylate glue. Am J Ophthalmol. 1987;104:437–438.
- Witte H, Molgaard IL. Giant papillary conjunctivitis in connection with corneoscleral supramid (nylon) suture knots. Acta Ophthalmol. 1984; 62:75–83.
- Srinivasan BD, Jacobiec FA, Iwamoto T, De Voe AG. Giant papillary conjunctivitis with ocular prostheses. Arch Ophthalmol. 1979; 97:892–895.
- Katelaris CH. Giant papillary conjunctivitis. Acta Ophthalmol Scan. 1999;228(Suppl.): 17–20.
- Fowler SA, Korb DR, Finnemore VM, Allansmith MR. Surface deposits on worn hard contact lenses. Arch Ophthalmol. 1984; 102(5):757–759.
- Allansmith MR, O'Connor GR. Immunoglobulins: structure, function and relation to the eye. Surv Ophthalmol. 1970;14(5):367–4.02.
- Leonardi A. Pathophysiology of allergic conjunctivitis. Acta Ophthalmol Scan. 1999;228(Suppl.): 21–23.
- Buckley RJ. Allergic eye disease-a clinical challenge. Guth Exp Allergy. 1998;28(6; Suppl.):39–43.
- Metz DP, Bacon AS, Holgate S, Lightman SL. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immun. 1996;98: 686–696.
- Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 1994;179:881–887.
- Resnick MB, Weller PE Mechanisms of eosinophil recruitment. Am J Respir Cell Mol. 1993;8:349–355.
- Nagase H, Yamaguchi M, Jibiki S, et al. Eosinophil chemotaxis by chemokines: a study by a simple photometric assay. Allergy. 1999;54:944–950.
- Gutierrez-Ramos JC, Lloyd C, Gonzalo JA. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today. 1999;20:500–504.
- Fukagawa K, Nakajima T, Tsubota K, et al. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immun. 1999;103:1220–1221.
- Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the timbal form of vernal keratoconjunctivitis. Brit J Ophthalmol. 2000;84:1360–1366.
- Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997;159: 4593–4601.
- Trocme SD, Kephart GM, Allansmith MR, et al. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol. 1989;108:57–63.
- Uguccioni M, Mackay CR, Ochensberger B, et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 1997;100: 1137–1143.
- Ponath PD, Qin S, Post TW, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 1996;183: 2437–2448.
- Daugherty BL, Siciliano SJ, DeMartino JA, et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996;183: 2349–2354.
- Lilly CM, Woodruff PG, Camargo CA, et al. Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol. 1999;104: 786–790.
- Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol. 1997;17: 683-69o.
- Yawalkar N, Uguccioni M, Scharer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol. 1999; 113:43–48.
- Yukari J, Fukagawa K, Takano Y, et al. Eotaxin is produced from corneal keratocytes but not from corneal epithelial cells. Invest Ophth Vis Sci. 2000; 41:1919–B165.
- Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13. Invest Ophth Vis Sci. 2000; 41:1448–1453.
- Irkec M, Bozkurt B, Kerimoglu H, et al. Topical Olopatadine decreases tear eotaxin in patients with seasonal allergic conjunctivitis (SAC). Invest Ophth Vis Sci. 2001;42: 3092–B234.
- Trocme SD, Hallberg CK, Gill KS, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophth Vis Sci. 1997:38:593–599.